Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
06/2003
06/05/2003CA2468422A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
06/05/2003CA2467966A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma
06/05/2003CA2467665A1 2,w-diaminocarboxylic acid compounds
06/05/2003CA2464094A1 Methods for ligand discovery
06/04/2003EP1315708A1 Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
06/04/2003EP1038863B1 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof
06/04/2003EP0966439B1 Certain cyclic thio substituted acylaminoacid amide derivatives
06/04/2003EP0964849B1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
06/04/2003EP0938712B1 System and method for remotely grouping contents of an action history stack
06/04/2003EP0783507B1 Compounds useful as antiproliferative agents and garft inhibitors
06/04/2003CN1422266A Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
06/04/2003CN1422265A Method for producing benzo annelated heterocycles
06/04/2003CN1422250A Alpha-sulfin-and alpha-sulfonamino acid amide derivatives
06/04/2003CN1422249A Novel alpha-sulfin-and alpha-sulfonamino acid amides
06/04/2003CN1422246A Malonamic acids and derivatives thereof as thyroid receptor ligands
06/04/2003CN1110493C Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors
06/03/2003US6573390 Muscle relaxant, hypotensive agent, respiratory system disorders, gastrointestinal disorders, fertility, incontinence, shock, antiinflammatory agents, immunology, bone disorders, antiproliferative agents
06/03/2003CA2053954C Process for the preparation of nitroguanidine derivatives
05/2003
05/30/2003WO2003044009A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003044008A1 Light-switchable gelator
05/30/2003WO2003044000A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003043975A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
05/30/2003WO2003043958A1 Method for the production of vinyl-arenes, -heteroarenes and 1,3-dienes from aryl-, heteroaryl- or vinyl-carboxylic acid derivatives
05/30/2003WO2003010141A3 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure
05/30/2003CA2467798A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
05/30/2003CA2466733A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003CA2466491A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/29/2003US20030100681 Crosslinkable monomers for novel nonlinear optical polymers
05/29/2003US20030100580 Benzenesulfonamide derivatives; for treatment of cardiovascular disorders
05/29/2003US20030100559 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease
05/29/2003US20030100441 Polymerization of olefin
05/28/2003EP1314719A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
05/28/2003EP1313729A2 Design and synthesis of thiophene derived nlo materials for electro-optic applications
05/28/2003EP1313724A1 N-heteroarylmethyl-p-phenylendiamine derivatives and compounds containing oxidation colouring agents
05/28/2003EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
05/28/2003EP1313701A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
05/28/2003EP0973763B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
05/28/2003CN1420879A Substd. pyridines and pyridazines with angiogenesis inhibiting activity
05/28/2003CN1420116A Process and apparatus for synthesis of thiophene
05/28/2003CN1109683C 2-arylbenzo [b] thiophenes useful for treatment of estrogen deprivation syndrome
05/28/2003CN1109679C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
05/28/2003CN1109544C Beta-alkoxyacrylates against malaria
05/27/2003US6569882 Viricides; enzyme inhibitors
05/27/2003US6569878 Substituted 4-amino-thiazol-2-yl compounds as cyclin-dependent kinase inhibitors
05/27/2003US6569863 Bicyclic heteroamatic compounds useful as LH agonists
05/27/2003CA2268847C Substituted oximes derivatives useful as neurokinin antagonists
05/27/2003CA2209391C New heterocyclic biaryl compounds and their use in human or veterinary medicine and in cosmetics
05/22/2003WO2003042168A1 NOVEL α-OXYGENATED OR α-THIOLATED CARBOXYLIC ACID PHENETHYLAMIDE DERIVATIVES
05/22/2003WO2003042167A1 NOVEL α-OXYGENATED OR α-THIOLATED CARBOXYLIC ACID PENETHYLAMIDE DERIVATIVES
05/22/2003WO2003042135A2 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
05/22/2003WO2003041728A1 Novel phenyl-propargylether derivatives
05/22/2003WO2003041658A2 Process for the preparation of 3,7-disubstituted-2,3,4,5- tetrahydro-1h-1,4-benzodiazepine compounds
05/22/2003WO2003041649A2 Cyanoalkylamino derivatives as protease inhibitors
05/22/2003US20030097007 Alkylation of 3,4- dihydroxythiophene-2, 5-dicarboxylic esters or their alkali metal or alkaline earth metal salts with alkylating agents in a polar diluent in the presence of quaternary onium salts
05/22/2003US20030097004 3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists
05/22/2003US20030096864 Compounds to treat alzheimer's disease
05/22/2003US20030096844 Cannabinoid receptor ligands
05/22/2003US20030096825 Antiviral activity; treatment of HIV and AIDS
05/22/2003US20030096818 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/22/2003US20030096806 For use as pesicides, herbicides; crop protection
05/22/2003US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders
05/22/2003US20030095985 Immunogenic conjugates of Gram-negative bacterial autoinducer molecules and antibodies raised against the same
05/22/2003US20030093867 Hair dyes; intense, stable blue color shades in addition to natural, purple or violet ones
05/22/2003CA2466449A1 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
05/22/2003CA2466115A1 Cyanoalkylamino derivatives as protease inhibitors
05/22/2003CA2464775A1 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
05/21/2003EP1312602A1 Amidino derivatives, and anticoagulants and thrombosis therapeutic agents containing them
05/21/2003EP1312601A1 Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
05/21/2003EP1311499A2 Bicyclic compounds as h3 receptor ligands
05/21/2003EP1311482A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
05/21/2003EP1311478A1 Novel thiourea compounds and the pharmaceutical compositions containing the same
05/21/2003EP1311477A1 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same
05/21/2003EP1311475A1 Novel aminocyclohexane derivatives
05/21/2003EP1071656B1 Fluorovinyloxyacetamides, process for preparing same and herbicidal composition comprising same
05/21/2003CN1419547A Compounds exhibiting thrombopoietin receptor agaonism
05/21/2003CN1109031C Bicycle-aromatic compound
05/21/2003CN1109030C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
05/20/2003US6566547 Fungicides
05/20/2003US6566536 Thienylsulphonylamino(thio)carbonyl compounds
05/20/2003US6566381 For therapy of arthritis, cancer, cardiovascular disorder, skin disorder, ocular disorder, inflammation and gum disease
05/20/2003US6566366 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
05/20/2003US6565997 Superior in vibration transmittability between ceramic substrate and piezoelectric
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/15/2003WO2003040142A1 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase
05/15/2003WO2003040126A1 φ-CYCLOALKYL 17-HETEROARYL PROSTAGLANDIN E2 ANALOGS AS EP2-RECEPTOR AGONISTS
05/15/2003WO2003040118A1 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003040086A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003WO2003039549A2 Selective antibacterial agents
05/15/2003WO2003039529A1 Selective antibacterial agents
05/15/2003WO2003007071A3 Novel nonlinear optical compounds and polymers
05/15/2003US20030092869 Crosslinking; heat resistance, stability
05/15/2003US20030092769 Diaryl-enynes
05/15/2003US20030092744 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
05/15/2003US20030092715 Aryl and biaryl compounds having MCH modulatory activity
05/15/2003US20030092708 Anticholesterol agents; cardiovascular disorders; antilipemic agents
05/15/2003US20030092678 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
05/15/2003US20030089273 A dye in ink formulations, soluble in solvent alcohol and water solution; invisible under ordinary light, become fluorescence under ultraviolet light
05/15/2003CA2466517A1 .omega.-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
1 ... 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 ... 329